Every material Form 8-K MYOMO, INC. has filed with the SEC since May 13, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Myomo reported second quarter 2026 revenue of $11.7 million, up 21% from a year earlier, and narrowed its net loss to $4.0 million, or $0.09 per share, from $4.6 million, or $0.11 per share. The company raised its full-year 2026 revenue guidance to $45 million to $47 million, which signals expected higher sales for shareholders.
Q2 2026 revenue was $11.7 million, up 21% from $9.7 million in Q2 2025; gross margin was 72.1% versus 62.7%.
Q2 2026 net loss was $4.0 million ($0.09 per share), including a $1.2 million non-cash derivative charge, compared with $4.6 million ($0.11 per share) a year earlier.
Full-year 2026 revenue guidance was raised to $45 million to $47 million; Q3 2026 revenue is expected at $11.5 million to $12.0 million.
Cash, cash equivalents and short-term investments were $13.5 million as of June 30, 2026; Q2 cash used in operating activities was $1.9 million.
At its June 25, 2026 annual meeting, Myomo stockholders approved raising the company's authorized common stock to 100,000,000 shares and adding 1,833,000 shares to the 2018 Stock Option and Incentive Plan. Stockholders also elected Paul R. Gudonis and Thomas F. Kirk as Class III directors and approved the other proposals, including an advisory say-on-pay vote. The share increases matter to existing holders because they expand the shares the company can issue, though the filing does not state the prior authorized share count.
Charter amendment raising authorized common stock to 100,000,000 shares took effect on filing with Delaware on June 25, 2026; votes: 20,723,545 for, 3,090,849 against, 146,921 abstain.
Plan amendment adds 1,833,000 shares; votes: 10,815,266 for, 3,676,078 against, 938,413 abstain.
Paul R. Gudonis (15,145,277 for) and Thomas F. Kirk (14,333,271 for) elected as Class III directors with terms expiring in 2029.
Advisory say-on-pay vote: 13,715,583 for, 696,112 against, 1,018,062 abstain; CBIZ CPAs P.C. ratified as auditor for fiscal 2026.
Myomo's board appointed Joseph M. Manko Jr. as a director effective May 9, 2026, filling a seat that brings the board to seven directors. Manko is the founder and Senior Principal of Horton Capital Management LLC, which the filing describes as a significant shareholder in the company, so the appointment links a major shareholder directly to the board.
Joseph M. Manko Jr., 60, was appointed effective May 9, 2026, as a Class I director serving until the 2027 annual meeting.
Manko is Senior Principal of Horton Capital Management LLC (Horton Fund), which he founded in 2013 and which is a significant shareholder in Myomo.
Manko has not been appointed to any board committee and has an indemnification agreement with the company.
Non-chair directors receive a $60,000 annual cash retainer and an annual restricted stock unit grant with a $85,000 grant date fair value; Manko will be paid the same way after the 2026 annual meeting.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every MYOMO, INC. filing is on SEC EDGAR ↗. 8-K briefs of other companies →